Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIORESORBABLE MEDICAL POLYMER INDUSTRY
2.1 Summary about Bioresorbable Medical Polymer Industry
2.2 Bioresorbable Medical Polymer Market Trends
2.2.1 Bioresorbable Medical Polymer Production & Consumption Trends
2.2.2 Bioresorbable Medical Polymer Demand Structure Trends
2.3 Bioresorbable Medical Polymer Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Polylactic Acid (PLA)
4.2.2 Polyglycolic Acid (PGA)
4.2.3 Polysaccharides
4.2.4 Polycaprolactone (PCL)
4.2.5 PLGA
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Drug Delivery
4.3.2 Orthopedics
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Polylactic Acid (PLA)
5.2.2 Polyglycolic Acid (PGA)
5.2.3 Polysaccharides
5.2.4 Polycaprolactone (PCL)
5.2.5 PLGA
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Drug Delivery
5.3.2 Orthopedics
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Polylactic Acid (PLA)
6.2.2 Polyglycolic Acid (PGA)
6.2.3 Polysaccharides
6.2.4 Polycaprolactone (PCL)
6.2.5 PLGA
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Drug Delivery
6.3.2 Orthopedics
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Polylactic Acid (PLA)
7.2.2 Polyglycolic Acid (PGA)
7.2.3 Polysaccharides
7.2.4 Polycaprolactone (PCL)
7.2.5 PLGA
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Drug Delivery
7.3.2 Orthopedics
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Polylactic Acid (PLA)
8.2.2 Polyglycolic Acid (PGA)
8.2.3 Polysaccharides
8.2.4 Polycaprolactone (PCL)
8.2.5 PLGA
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Drug Delivery
8.3.2 Orthopedics
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Polylactic Acid (PLA)
9.2.2 Polyglycolic Acid (PGA)
9.2.3 Polysaccharides
9.2.4 Polycaprolactone (PCL)
9.2.5 PLGA
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Drug Delivery
9.3.2 Orthopedics
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Evonik
10.1.2 Corbion
10.1.3 DSM
10.1.4 Mitsui Chemicals
10.1.5 PCAS
10.1.6 Poly-Med
10.1.7 KLS Martin
10.2 Bioresorbable Medical Polymer Sales Date of Major Players (2017-2020e)
10.2.1 Evonik
10.2.2 Corbion
10.2.3 DSM
10.2.4 Mitsui Chemicals
10.2.5 PCAS
10.2.6 Poly-Med
10.2.7 KLS Martin
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
1.Table Bioresorbable Medical Polymer Product Type Overview
2.Table Bioresorbable Medical Polymer Product Type Market Share List
3.Table Bioresorbable Medical Polymer Product Type of Major Players
4.Table Brief Introduction of Evonik
5.Table Brief Introduction of Corbion
6.Table Brief Introduction of DSM
7.Table Brief Introduction of Mitsui Chemicals
8.Table Brief Introduction of PCAS
9.Table Brief Introduction of Poly-Med
10.Table Brief Introduction of KLS Martin
11.Table Products & Services of Evonik
12.Table Products & Services of Corbion
13.Table Products & Services of DSM
14.Table Products & Services of Mitsui Chemicals
15.Table Products & Services of PCAS
16.Table Products & Services of Poly-Med
17.Table Products & Services of KLS Martin
18.Table Market Distribution of Major Players
19.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
20.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
21.Table Global Bioresorbable Medical Polymer Market Forecast (Million USD) by Region 2021f-2026f
22.Table Global Bioresorbable Medical Polymer Market Forecast (Million USD) Share by Region 2021f-2026f
23.Table Global Bioresorbable Medical Polymer Market Forecast (Million USD) by Demand 2021f-2026f
24.Table Global Bioresorbable Medical Polymer Market Forecast (Million USD) Share by Demand 2021f-2026f